Bruce E. Sands, MD, MS Joins The Mount Sinai Medical Center to Lead The Division of Gastroenterology
Bruce E. Sands, MD, MS will join Mount Sinai School of Medicine as Chief of the Henry D. Janowitz Division of Gastroenterology in June of 2010.
Bruce E. Sands, MD, MS will join Mount Sinai School of Medicine as Chief of the Henry D. Janowitz Division of Gastroenterology in June of 2010. Dr. Sands’s world-renowned experience in research, patient care, and advocacy in Crohn’s disease and ulcerative colitis make him a welcome leader at Mount Sinai School of Medicine’s nationally-ranked Gastroenterology program.
“Dr. Sands’ combination of skill and experience as a researcher, clinician, educator, and administrator provide the necessary foundation for him to follow in the footsteps of the giants of the field who built Mount Sinai’s reputation as one of the world’s top gastroenterology programs,” said Paul E. Klotman, MD, Chairman of the Samuel Bronfman Department of Medicine and Murray M. Rosenberg Professor of Medicine, Mount Sinai School of Medicine.
Showing his passion for improving patient care, Dr. Sands is chair of the Clinical Research Alliance of the Crohn's and Colitis Foundation of America. He is committed to participating in ongoing research and has been published in several journals, including the New England Journal of Medicine, Gastroenterology and Gut. Dr. Sands is also a reviewer for many prominent journals, including Gastroenterology and the New England Journal of Medicine, and an Associate Editor for the journal Inflammatory Bowel Diseases.
Recognized by his colleagues at Massachusetts General Hospital for his extensive work in gastrointestinal diseases, Dr. Sands is the Medical Co-Director of the Crohn's & Colitis Center. He is an Associate Professor of Medicine at Harvard Medical School, and recently served as Acting Chief of the Gastrointestinal Unit at Massachusetts General Hospital.
Several organizations have acclaimed Dr. Sands for his commitment to research and patient care. He is Vice-Chair of the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association (AGA), and a Fellow of the AGA and the American College of Gastroenterology. In 2006 he was named Humanitarian of the Year by the New England Chapter of the Crohn’s and Colitis Foundation of America, and the Massachusetts General Physician Organization honored him for “Excellence in Action” in recognition of his distinguished patient care. Dr. Sands has consistently been chosen as one of the “Best Doctors in America” by Castle Connolly Medical Ltd.
“Mount Sinai has a highly accomplished history in gastroenterology,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Mount Sinai School of Medicine, and Executive Vice President for Academic Affairs, The Mount Sinai Medical Center. ”We look forward to making further advances in the field under the guidance of such a high-caliber leader.”
Dr. Sands received his medical degree at Boston University School of Medicine in Massachusetts. His postgraduate training included an internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. He also completed clinical and research fellowships at Massachusetts General Hospital. He is certified by the American Board of Internal Medicine and holds subspecialty certification in gastroenterology. In addition, he has completed a Master of Science in Epidemiology at Harvard School of Public Health.
About the Henry D. Janowitz Division of Gastroenterology
It was at Mount Sinai that a number of gastrointestinal diseases were first identified or studied with the goal of finding a treatment or cure. These include the first descriptions of Crohn’s disease and benign paroxysmal peritonitis, among many others. Today, Mount Sinai gastroenterologists care for more patients with inflammatory bowel disease (IBD) then any medical center in the country. Gastroenterologists from throughout the New York tri-state area send their most challenging cases to Mount Sinai, where clinicians and researchers are developing new tools for non-invasive diagnosis of gastrointestinal cancers as well as reaching out to the community to develop culturally appropriate means of encouraging cancer screening.
U.S. News & World Report has rated Mount Sinai among the top 10 hospitals in the country and number one in New York for the treatment of gastrointestinal disorders ever since it began publishing its hospital surveys in 1989. In addition, more Mount Sinai gastroenterologists are included in New York Magazine’s “Best Doctors” listing than any other institution in the city.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.